Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy aTyr Pharma stock
Learn how to easily invest in aTyr Pharma stock.
aTyr Pharma Inc is a biotechnology business based in the US. aTyr Pharma shares (LIFE) are listed on the NASDAQ and all prices are listed in US Dollars. aTyr Pharma employs 49 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in aTyr Pharma
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – LIFE – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
aTyr Pharma stock price (NASDAQ: LIFE)Use our graph to track the performance of LIFE stocks over time.
aTyr Pharma shares at a glance
|Latest market close||$2.85|
|52-week range||$2.60 - $13.10|
|50-day moving average||$3.23|
|200-day moving average||$6.14|
|Wall St. target price||$17.17|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-1.72|
Buy aTyr Pharma shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy aTyr Pharma stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
aTyr Pharma price performance over time
|1 week (2022-06-28)||1.42%|
|1 month (2022-06-01)||2.15%|
|3 months (2022-04-04)||-49.20%|
|6 months (2022-01-03)||-62.20%|
|1 year (2021-07-02)||-41.12%|
|2 years (2020-07-02)||-33.10%|
|3 years (2019-07-05)||5.0463|
|5 years (2017-07-03)||3.15|
aTyr Pharma financials
|Revenue TTM||$2.1 million|
|Gross profit TTM||$-23,264,000|
|Return on assets TTM||-30.64%|
|Return on equity TTM||-52.43%|
|Market capitalisation||$80 million|
TTM: trailing 12 months
aTyr Pharma share dividends
We're not expecting aTyr Pharma to pay a dividend over the next 12 months.
Have aTyr Pharma's shares ever split?
aTyr Pharma's shares were split on a 1:14 basis on 30 June 2019. So if you had owned 14 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your aTyr Pharma shares – just the quantity. However, indirectly, the new 1300% higher share price could have impacted the market appetite for aTyr Pharma shares which in turn could have impacted aTyr Pharma's share price.
aTyr Pharma share price volatility
Over the last 12 months, aTyr Pharma's shares have ranged in value from as little as $2.6 up to $13.1. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while aTyr Pharma's is 1.569. This would suggest that aTyr Pharma's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
aTyr Pharma overview
aTyr Pharma, Inc. , a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for treatment of other interstitial lung diseases (ILDs), such as chronic hypersensitivity pneumonitis and connective tissue disease related ILD. It is also developing ATYR2810, a fully humanized monoclonal antibody that is in preclinical development for the treatment of solid tumors. It has collaboration and license agreement with Kyorin Pharmaceutical Co. , Ltd. for the development and commercialization of efzofitimod for ILDs in Japan.
aTyr Pharma in the news
aTyr Pharma Announces FGFR4 as Receptor Target for AARS tRNA Synthetase Fragment
aTyr Pharma to Present Findings from its tRNA Synthetase Platform at the International 28th tRNA Conference
Frequently asked questionsWhat percentage of aTyr Pharma is owned by insiders or institutions?
Currently 3.03% of aTyr Pharma shares are held by insiders and 75.454% by institutions. How many people work for aTyr Pharma?
Latest data suggests 49 work at aTyr Pharma. When does the fiscal year end for aTyr Pharma?
aTyr Pharma's fiscal year ends in December. Where is aTyr Pharma based?
aTyr Pharma's address is: 3545 John Hopkins Court, San Diego, CA, United States, 92121 What is aTyr Pharma's ISIN number?
aTyr Pharma's international securities identification number is: US0021202025 What is aTyr Pharma's CUSIP number?
aTyr Pharma's Committee on Uniform Securities Identification Procedures number is: 002120103
More guides on Finder
How to buy Citrine Global (CTGL) stock when it goes public
Everything we know about the Citrine Global IPO, plus information on how to buy in.
How to buy Genelux Corporation (GNLX) stock when it goes public
Everything we know about the Genelux Corporation IPO, plus information on how to buy in.
How to buy Magic Empire Global (MEGL) stock when it goes public
Everything we know about the Magic Empire Global IPO, plus information on how to buy in.
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Ask an Expert